From: Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition
Salirasib treatment
50 μM
100 μM
150 μM
HepG2 (S.E.M.)
54%*** (±5%)
34% *** (±3%)
2% *** (±0%)
Cell line
Huh7 (S.E.M.)
70%** (±6%)
52%*** (±3%)
1%*** (±0%)
Hep3B (S.E.M.)
31%*** (±3%)
5%*** (±0%)
0%***